About: Rezolute, Inc., a late-stage rare disease company, focuses developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism (HI) in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody which is in Phase 3 clinical trial to treat tumor HI indication, as well as congenital HI. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.22 (+2.68%)
RZLT NASDAQ Rezolute Inc
Rezolute Inc share price
Atividade de preço de RZLT
Último preço
$ 4,120
Variação (24h)
-0,10 USD (2,37%)
Volume
754.43K
Volume (média 4 sem.)
-
Abertura
$ 4,20
Variação do dia
$ 4,08 - $ 4,33
Fechamento anterior
$ 4,22
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
RZLT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals